Remdesivir: Preliminary Data and Clinical Use Versus Recommended Use

Pediatrics. 2021 May;147(5):e2021050212. doi: 10.1542/peds.2021-050212.

Authors

Angelique E Boutzoukas¹, Daniel K Benjamin Jr², Kanecia O Zimmerman¹

Affiliations

¹ Duke Clinical Research Institute and Department of Pediatrics, School of Medicine, Duke University, Durham, North Carolina.
² Duke Clinical Research Institute and Department of Pediatrics, School of Medicine, Duke University, Durham, North Carolina [email protected].

No abstract available

Publication types

Research Support, N.I.H., Extramural
Comment

MeSH terms

Adenosine Monophosphate / analogs & derivatives
Alanine* / analogs & derivatives
Humans
Preliminary Data

Substances

remdesivir
Adenosine Monophosphate
Alanine

Grants and funding